Publications of Institute of Radiopharmaceutical Cancer Research - Year 2019
14 Publications2019
The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
Tunger, A.; Sommer, U.; Wehner, R.; Kubasch, A. S.; Grimm, M.-O.; et al. (10 authors)
-
Journal of Clinical Medicine 8(2019)10, 1534
DOI: 10.3390/jcm8101534
Conventional CARs versus modular CARs
Feldmann, A.; Arndt, C.; Koristka, S.; Berndt, N.; Bergmann, R.; et al. (6 authors)
-
Cancer Immunology, Immunotherapy 68(2019)10, 1713-1719
DOI: 10.1007/s00262-019-02399-5
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
Arndt, C.; Feldmann, A.; Koristka, S.; Schäfer, M.; Bergmann, R.; et al. (19 authors)
-
OncoImmunology 8(2019)9, 1659095
DOI: 10.1080/2162402X.2019.1659095
Theranostic CAR T cell targeting: A brief review
Arndt, C.; Bachmann, M.; Bergmann, R.; Berndt, N.; Feldmann, A.; et al. (6 authors)
-
Journal of Labelled Compounds and Radiopharmaceuticals 62(2019)8, 533-540
DOI: 10.1002/jlcr.3727
Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC
Sinnes, J. P.; Nagel, J.; Waldron, B. P.; Maina, T.; Nock, B. A.; et al. (11 authors)
-
EJNMMI Research 9(2019), 48
DOI: 10.1186/s13550-019-0516-7
T cells engrafted with a UniCAR 28/ζ outperform UniCAR BB/ζ-transduced T cells in the face of regulatory T cell-mediated immunosuppression
Kegler, A.; Koristka, S.; Bergmann, R.; Berndt, N.; Arndt, C.; et al. (10 authors)
-
OncoImmunology 8(2019)9, e1621676
DOI: 10.1080/2162402X.2019.1621676
The UniCAR system: A modular CAR T cell approach to improve the safety of CAR T cells
-
Immunology Letters 211(2019), 13-22
DOI: 10.1016/j.imlet.2019.05.003
Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukemia
Fasslrinner, F.; Arndt, C.; Koristka, S.; Feldmann, A.; Altmann, H.; et al. (9 authors)
-
British Journal of Haematology 186(2019)5, 735-740
DOI: 10.1111/bjh.15975
An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells
Jureczek, J.; Bergmann, R.; Berndt, N.; Koristka, S.; Kegler, A.; et al. (10 authors)
-
Scientific Reports 9(2019)1, 10547
DOI: 10.1038/s41598-019-47044-4
Fluorescent Mouse Pheochromocytoma Spheroids Expressing Hypoxia-Inducible Factor 2 alpha: Morphologic and Radiopharmacologic Characterization
Seifert, V.; Liers, J.; Kniess, T.; Richter, S.; Bechmann, N.; et al. (10 authors)
-
Journal of Cellular Biotechnology 5(2019)2, 135-151
DOI: 10.3233/JCB-199005
ISSN: 2352-3689
Synthesis and preliminary radiopharmacological characterisation of an 11C-labelled azadipeptide nitrile as potential PET tracer for imaging of cysteine cathepsins
Laube, M.; Frizler, M.; Wodtke, R.; Neuber, C.; Belter, B.; et al. (10 authors)
-
Journal of Labelled Compounds and Radiopharmaceuticals 62(2019)8, 448-459
DOI: 10.1002/jlcr.3729
Tonic signaling and its effects on lymphopoiesis of CAR-armed hematopoietic stem and progenitor cells
Albert, S.; Koristka, S.; Gerbaulet, A.; Cartellieri, M.; Arndt, C.; et al. (15 authors)
-
Journal of Immunology 202(2019)6, 1735-1746
DOI: 10.4049/jimmunol.1801004
Neoadjuvant radiochemotherapy significantly alters the phenotype of plasmacytoid dendritic cells and 6-sulfo LacNAc+ monocytes in rectal cancer
Wagner, F.; Hölig, U.; Wilczkowski, F.; Sommer, U.; Wehner, R.; et al. (23 authors)
-
Frontiers in Immunology 10(2019), 602
DOI: 10.3389/fimmu.2019.00602
Anti-CAR engineered T cells for epitope-based elimination of autologous CAR T cells
Koristka, S.; Ziller-Walter, P.; Bergmann, R.; Arndt, C.; Feldmann, A.; et al. (11 authors)
-
Cancer Immunology, Immunotherapy (2019), 1401-1415
DOI: 10.1007/s00262-019-02376-y
Years: 2023 2022 2021 2020 2019 2018 2017 2016 2015
